首页 > 最新文献

Eye & Contact Lens-Science and Clinical Practice最新文献

英文 中文
Prevalence of Keratoconus Based on Scheimpflug Corneal Tomography Metrics in a Pediatric Population From a Chicago-Based School Age Vision Clinic. 基于 Scheimpflug 角膜断层扫描指标的芝加哥学龄儿童视力诊所小儿角膜炎患病率。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-03-01 Epub Date: 2024-02-07 DOI: 10.1097/ICL.0000000000001072
Jennifer S Harthan, John D Gelles, Sandra S Block, William Tullo, Andrew S Morgenstern, Becky Su, Daniel Chung, Austin Yu, Steven A Greenstein, Peter S Hersh, Steven Barry Eiden

Purpose: Determine the pediatric prevalence of keratoconus (KC) using Scheimpflug corneal tomography.

Methods: A prospective observational study was done on subjects aged 3 to 18 years at the Princeton Vision Clinic, Chicago, IL. Scheimpflug tomography (Pentacam HR, OCULUS Optikgerate GmbH) scans (Belin/Ambrósio Enhanced Ectasia BAD3) yielded BAD Final D (Final D) and Back Elevation at the Thinnest Point (BETP) measurements. Criteria differentiating non-KC from KC suspects & KC were, Non-KC -Final D <2.00 in both eyes; KC suspect -Final D ≥2.00 and <3.00 in combination with BETP ≥18 μm for myopia and ≥28 μm for hyperopia/mixed astigmatism in at least one eye; and KC -Final D of ≥3.00 with BETP ≥18 μm for myopia or ≥28 μm for hyperopia/mixed astigmatism in at least one eye. Two thousand two hundred and six subjects were recorded, removing duplicate and poor-quality scans leaving 2007 subjects.

Results: Of 2007 subjects, six were classified as KC -prevalence of 1:334, three subjects were KC suspects -prevalence of 1:669, and total prevalence of KC suspects and KC was 1:223.

Conclusion: The prevalence of KC in children is higher than previously reported, emphasizing the importance of sensitive screening for KC at its earliest manifestation as standard in pediatric comprehensive eye examinations.

目的:使用 Scheimpflug 角膜断层扫描确定小儿角膜炎(KC)的发病率:方法:伊利诺伊州芝加哥市普林斯顿视力诊所对 3 至 18 岁的受试者进行了一项前瞻性观察研究。Scheimpflug 层析成像(Pentacam HR,OCULUS Optikgerate GmbH)扫描(Belin/Ambrósio Enhanced Ectasia BAD3)得出了 BAD 最终 D 值(Final D)和最薄点后抬高值(BETP)。区分非 KC 与 KC 嫌疑人和 KC 的标准是:非 KC-最终 D 结果:在 2007 名受试者中,有 6 人被归类为 KC(患病率为 1:334),3 人被归类为 KC 嫌疑人(患病率为 1:669),KC 嫌疑人和 KC 的总患病率为 1:223:儿童 KC 患病率高于之前的报道,这强调了在 KC 最早出现时进行敏感筛查的重要性,并将其作为儿童眼科综合检查的标准。
{"title":"Prevalence of Keratoconus Based on Scheimpflug Corneal Tomography Metrics in a Pediatric Population From a Chicago-Based School Age Vision Clinic.","authors":"Jennifer S Harthan, John D Gelles, Sandra S Block, William Tullo, Andrew S Morgenstern, Becky Su, Daniel Chung, Austin Yu, Steven A Greenstein, Peter S Hersh, Steven Barry Eiden","doi":"10.1097/ICL.0000000000001072","DOIUrl":"10.1097/ICL.0000000000001072","url":null,"abstract":"<p><strong>Purpose: </strong>Determine the pediatric prevalence of keratoconus (KC) using Scheimpflug corneal tomography.</p><p><strong>Methods: </strong>A prospective observational study was done on subjects aged 3 to 18 years at the Princeton Vision Clinic, Chicago, IL. Scheimpflug tomography (Pentacam HR, OCULUS Optikgerate GmbH) scans (Belin/Ambrósio Enhanced Ectasia BAD3) yielded BAD Final D (Final D) and Back Elevation at the Thinnest Point (BETP) measurements. Criteria differentiating non-KC from KC suspects & KC were, Non-KC -Final D <2.00 in both eyes; KC suspect -Final D ≥2.00 and <3.00 in combination with BETP ≥18 μm for myopia and ≥28 μm for hyperopia/mixed astigmatism in at least one eye; and KC -Final D of ≥3.00 with BETP ≥18 μm for myopia or ≥28 μm for hyperopia/mixed astigmatism in at least one eye. Two thousand two hundred and six subjects were recorded, removing duplicate and poor-quality scans leaving 2007 subjects.</p><p><strong>Results: </strong>Of 2007 subjects, six were classified as KC -prevalence of 1:334, three subjects were KC suspects -prevalence of 1:669, and total prevalence of KC suspects and KC was 1:223.</p><p><strong>Conclusion: </strong>The prevalence of KC in children is higher than previously reported, emphasizing the importance of sensitive screening for KC at its earliest manifestation as standard in pediatric comprehensive eye examinations.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"121-125"},"PeriodicalIF":2.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Experiences With Therapeutic Contact Lenses and Dry Eye Disease. 患者使用治疗性隐形眼镜和干眼症的经验。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-01 DOI: 10.1097/ICL.0000000000001051
Ellen Shorter, Cherie B Nau, Jennifer S Fogt, Amy Nau, Muriel Schornack, Jennifer Harthan

Objectives: To report patient-reported experiences with dry eye disease and therapeutic contact lenses.

Methods: A survey was distributed to patients with dry eye disease. Demographics, Ocular Surface Disease Index (OSDI), systemic disease, contact lens history, and burden of care information were collected. Descriptive statistics are presented and categorized by nonlens, soft lens, and scleral lens (SL) wearers.

Results: Of 639 respondents, 15% (94/639) were currently using therapeutic soft or SLs (47 soft and 69 SL). Mid-day fogging or clouding of vision was reported by SL (75%, 50/67) and soft lens (62%, 29/47) wearers. Seventy-two percent of SL wearers spent more than 20 min daily on dry eye treatment while 43% of soft lens wearers spent more than 20 min. Median annual expenditure was higher for SL ($1,500, n=63) than nonlens ($500, n=371) or soft lens wearers ($700, n=43). Mean OSDI scores in all groups were in the severe category (51±22 years, n=401 nonlens wearers; mean age; 45±22 years, n=47 soft lens wearers; 60±24 years, n=69 SL wearers).

Conclusions: Mid-day fogging and blurring of vision was reported by most of the individuals using therapeutic lenses for dry eye disease. SL wearers allocate the most resources for dry eye care.

目的:报告患者报告的干眼病和治疗性隐形眼镜的经验。方法:对干眼症患者进行调查。收集人口统计学、眼表疾病指数(OSDI)、系统性疾病、隐形眼镜史和护理负担信息。描述性统计数据按非晶状体、软晶状体和巩膜晶状体(SL)佩戴者分类。结果:在639名受访者中,15%(94/639)目前正在使用治疗性软性或SL(47名软性和69名SL)。SL(75%,50/67)和软镜片(62%,29/47)佩戴者报告了日间视力模糊。72%的SL佩戴者每天花在干眼治疗上的时间超过20分钟,而43%的软性镜片佩戴者花在干眼睛治疗上的花费超过20分钟。SL(1500美元,n=63)的年支出中值高于非SL(500美元,n=371)或软性镜片配戴者(700美元,n=43)。所有组的平均OSDI评分均属于严重组(51±22岁,n=401名非配戴者;平均年龄;45±22岁;n=47名软性镜片配戴者;60±24岁,n=69名SL配戴者)。SL佩戴者为干眼护理分配了最多的资源。
{"title":"Patient Experiences With Therapeutic Contact Lenses and Dry Eye Disease.","authors":"Ellen Shorter, Cherie B Nau, Jennifer S Fogt, Amy Nau, Muriel Schornack, Jennifer Harthan","doi":"10.1097/ICL.0000000000001051","DOIUrl":"10.1097/ICL.0000000000001051","url":null,"abstract":"<p><strong>Objectives: </strong>To report patient-reported experiences with dry eye disease and therapeutic contact lenses.</p><p><strong>Methods: </strong>A survey was distributed to patients with dry eye disease. Demographics, Ocular Surface Disease Index (OSDI), systemic disease, contact lens history, and burden of care information were collected. Descriptive statistics are presented and categorized by nonlens, soft lens, and scleral lens (SL) wearers.</p><p><strong>Results: </strong>Of 639 respondents, 15% (94/639) were currently using therapeutic soft or SLs (47 soft and 69 SL). Mid-day fogging or clouding of vision was reported by SL (75%, 50/67) and soft lens (62%, 29/47) wearers. Seventy-two percent of SL wearers spent more than 20 min daily on dry eye treatment while 43% of soft lens wearers spent more than 20 min. Median annual expenditure was higher for SL ($1,500, n=63) than nonlens ($500, n=371) or soft lens wearers ($700, n=43). Mean OSDI scores in all groups were in the severe category (51±22 years, n=401 nonlens wearers; mean age; 45±22 years, n=47 soft lens wearers; 60±24 years, n=69 SL wearers).</p><p><strong>Conclusions: </strong>Mid-day fogging and blurring of vision was reported by most of the individuals using therapeutic lenses for dry eye disease. SL wearers allocate the most resources for dry eye care.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"59-64"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10843105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71428659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Autologous Serum and Platelet-Rich Plasma on Human Corneal Endothelial Cell Regeneration: A Comparative Study. 自体血清和富血小板血浆对人角膜内皮细胞再生影响的比较研究。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-29 DOI: 10.1097/ICL.0000000000001056
Emine Kilic-Toprak, Aysegul Cort-Donmez, Ibrahim Toprak

Objectives: To investigate the effects of autologous serum (AS) and platelet-rich plasma (PRP) on human corneal endothelial cell (HCEC) proliferation and apoptosis in comparison to Y-27632 as the commonly studied Rho-associated kinase (ROCK) inhibitor.

Methods: The human corneal endothelial primary cell line was used for this study. As the treatment groups, HCECs were incubated with AS, PRP, and Y-27632, whereas the control group received no treatment. Cell proliferation (measured by 5-bromo-2'-deoxyuridine [BrdU] incorporation) and apoptosis (based on the caspase-3 level) were compared between the control, Y-27632, AS, and PRP groups.

Results: In the Y-27632, AS, and PRP groups, the ratios of BrdU-incorporated cells were significantly higher (115±0.2%, 125±0.2%, 122±0.4% at 24 hr, and 138±2.4%, 160±0.2%, 142±0.2% at 48 hr, respectively) than in the control group (100±18.4% at 24 hr, 100±1.1% at 48 hr) ( P <0.05 for all). Furthermore, AS provided a higher HCEC proliferation ratio compared with the Y-27632 group at 24 and 48 hr ( P <0.05 for all). Caspase-3 was significantly lower in the AS group (60.3±3.3%) than in the control (100±2.3%), Y-27632 (101.9±5.2%), and PRP (101±6.8%) groups ( P <0.05 for all).

Conclusions: The results of this study demonstrated for the first time that AS and PRP promoted HCEC proliferation and AS significantly decreased apoptosis in HCECs. A superior effect on HCEC proliferation was also observed with AS compared with Y-27632. Future "autologous" regenerative therapeutic options for corneal endothelial failure may involve the utilization of AS and PRP owing to their accessibility, simplicity in preparation, immunologic compatibility, and donor-free nature.

目的:研究自体血清(AS)和富血小板血浆(PRP)对人角膜内皮细胞(HCEC)增殖和凋亡的影响,并与常用的rho相关激酶(ROCK)抑制剂Y-27632进行比较。方法:采用人角膜内皮原代细胞系进行研究。作为治疗组,HCECs与As、PRP和Y-27632孵育,对照组不进行任何处理。比较对照组、Y-27632组、AS组和PRP组的细胞增殖(以5-溴-2′-脱氧尿苷[BrdU]掺入测定)和细胞凋亡(以caspase-3水平测定)。结果:Y-27632、AS和PRP组brdu结合细胞的比例(24小时时分别为115±0.2%、125±0.2%、122±0.4%,48小时时分别为138±2.4%、160±0.2%、142±0.2%)显著高于对照组(24小时时分别为100±18.4%、48小时时分别为100±1.1%)(p结论:本研究结果首次证实AS和PRP促进HCEC增殖,AS显著降低HCEC凋亡。与Y-27632相比,AS对HCEC增殖的影响也更大。由于AS和PRP的可及性、制备简单、免疫相容性和无供体性,未来角膜内皮衰竭的“自体”再生治疗选择可能包括使用AS和PRP。
{"title":"Effects of Autologous Serum and Platelet-Rich Plasma on Human Corneal Endothelial Cell Regeneration: A Comparative Study.","authors":"Emine Kilic-Toprak, Aysegul Cort-Donmez, Ibrahim Toprak","doi":"10.1097/ICL.0000000000001056","DOIUrl":"10.1097/ICL.0000000000001056","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the effects of autologous serum (AS) and platelet-rich plasma (PRP) on human corneal endothelial cell (HCEC) proliferation and apoptosis in comparison to Y-27632 as the commonly studied Rho-associated kinase (ROCK) inhibitor.</p><p><strong>Methods: </strong>The human corneal endothelial primary cell line was used for this study. As the treatment groups, HCECs were incubated with AS, PRP, and Y-27632, whereas the control group received no treatment. Cell proliferation (measured by 5-bromo-2'-deoxyuridine [BrdU] incorporation) and apoptosis (based on the caspase-3 level) were compared between the control, Y-27632, AS, and PRP groups.</p><p><strong>Results: </strong>In the Y-27632, AS, and PRP groups, the ratios of BrdU-incorporated cells were significantly higher (115±0.2%, 125±0.2%, 122±0.4% at 24 hr, and 138±2.4%, 160±0.2%, 142±0.2% at 48 hr, respectively) than in the control group (100±18.4% at 24 hr, 100±1.1% at 48 hr) ( P <0.05 for all). Furthermore, AS provided a higher HCEC proliferation ratio compared with the Y-27632 group at 24 and 48 hr ( P <0.05 for all). Caspase-3 was significantly lower in the AS group (60.3±3.3%) than in the control (100±2.3%), Y-27632 (101.9±5.2%), and PRP (101±6.8%) groups ( P <0.05 for all).</p><p><strong>Conclusions: </strong>The results of this study demonstrated for the first time that AS and PRP promoted HCEC proliferation and AS significantly decreased apoptosis in HCECs. A superior effect on HCEC proliferation was also observed with AS compared with Y-27632. Future \"autologous\" regenerative therapeutic options for corneal endothelial failure may involve the utilization of AS and PRP owing to their accessibility, simplicity in preparation, immunologic compatibility, and donor-free nature.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"106-111"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138452922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Inflammatory and Cytological Effect of Repeated Povidone-Iodine Application in Patients Receiving Intravitreal Injections. 玻璃体内注射患者反复应用聚维酮碘对炎症和细胞学的影响。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-10-04 DOI: 10.1097/ICL.0000000000001044
Ersin Akbulut, Furkan Kirik, Cansu Ekinci Aslanoglu, Emine Rümeysa Hekimoglu, Ebru Haciosmanoglu Aldogan, Mehmet Hakan Ozdemir

Objective: To investigate the effect of repeated povidone-iodine (PVI) application on the ocular surface parameters of patients who received intravitreal injections.

Materials and methods: In this prospective study, 52 eyes of 52 patients with age-related macular degeneration who underwent unilateral intravitreal injection at least three times in the last 1 year (intravitreal injection [IVI] group), 52 fellow eyes with no previous intravitreal injection (NIVI group), and 51 eyes of 51 healthy subjects (control) were included. Tear break-up time (TBUT), the Schirmer test, the Oxford staining score, the Ocular Surface Disease Index questionnaire, conjunctival impression cytology, and tear inflammatory cytokine levels (interleukin [IL]-1β and IL-6) were analyzed in all participants.

Results: The IVI group had lower TBUT and higher Oxford staining score than the NIVI and control groups ( P <0.05). No significant difference was found between the groups in the Schirmer test ( P =0.161). Conjunctival impression cytology analysis revealed that the IVI group had a significantly lower goblet cell count and significantly higher Nelson staging result than the NIVI and control groups ( P <0.05). As a result of tear cytokine analysis, although IVI and NIVI groups had higher IL-1β and IL-6 levels than the control group ( P <0.05), there was no difference between NIVI and IVI groups ( P ≥0.05).

Conclusions: Repeated PVI application caused cytotoxic injury to the ocular surface, resulting in goblet cell loss and squamous metaplasia of epithelial cells. As a result, the stability of the tear film layer was found to be impaired and ocular surface-related symptoms developed in patients.

目的:探讨反复应用聚维酮碘(PVI)对玻璃体内注射患者眼表参数的影响。材料和方法:在这项前瞻性研究中,包括52名年龄相关性黄斑变性患者的52只眼睛,这些患者在过去1年中至少接受了三次单侧玻璃体内注射(玻璃体内注射[IVI]组),52只以前没有玻璃体内注射的同眼(NIVI组),以及51名健康受试者的51只眼睛(对照)。分析所有参与者的泪液破裂时间(TBUT)、Schirmer试验、Oxford染色评分、眼表疾病指数问卷、结膜印模细胞学和泪液炎性细胞因子水平(白细胞介素[IL]-1β和IL-6)。结果:IVI组的TBUT较低,Oxford染色评分高于NIVI组和对照组(P结论:反复应用PVI会对眼表造成细胞毒性损伤,导致杯状细胞丢失和上皮细胞鳞状化生。因此,患者泪膜层的稳定性受损,并出现眼表相关症状。
{"title":"The Inflammatory and Cytological Effect of Repeated Povidone-Iodine Application in Patients Receiving Intravitreal Injections.","authors":"Ersin Akbulut, Furkan Kirik, Cansu Ekinci Aslanoglu, Emine Rümeysa Hekimoglu, Ebru Haciosmanoglu Aldogan, Mehmet Hakan Ozdemir","doi":"10.1097/ICL.0000000000001044","DOIUrl":"10.1097/ICL.0000000000001044","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of repeated povidone-iodine (PVI) application on the ocular surface parameters of patients who received intravitreal injections.</p><p><strong>Materials and methods: </strong>In this prospective study, 52 eyes of 52 patients with age-related macular degeneration who underwent unilateral intravitreal injection at least three times in the last 1 year (intravitreal injection [IVI] group), 52 fellow eyes with no previous intravitreal injection (NIVI group), and 51 eyes of 51 healthy subjects (control) were included. Tear break-up time (TBUT), the Schirmer test, the Oxford staining score, the Ocular Surface Disease Index questionnaire, conjunctival impression cytology, and tear inflammatory cytokine levels (interleukin [IL]-1β and IL-6) were analyzed in all participants.</p><p><strong>Results: </strong>The IVI group had lower TBUT and higher Oxford staining score than the NIVI and control groups ( P <0.05). No significant difference was found between the groups in the Schirmer test ( P =0.161). Conjunctival impression cytology analysis revealed that the IVI group had a significantly lower goblet cell count and significantly higher Nelson staging result than the NIVI and control groups ( P <0.05). As a result of tear cytokine analysis, although IVI and NIVI groups had higher IL-1β and IL-6 levels than the control group ( P <0.05), there was no difference between NIVI and IVI groups ( P ≥0.05).</p><p><strong>Conclusions: </strong>Repeated PVI application caused cytotoxic injury to the ocular surface, resulting in goblet cell loss and squamous metaplasia of epithelial cells. As a result, the stability of the tear film layer was found to be impaired and ocular surface-related symptoms developed in patients.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"73-78"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41146410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing an Exposure Keratopathy Prevention Strategy in Mechanically Ventilated Patients: A Retrospective Study. 评估机械通气患者暴露性角膜病变预防策略:一项回顾性研究。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-07 DOI: 10.1097/ICL.0000000000001055
Ayobami Adebayo, Jenna Tauber, Jennifer Tingley, Lewis A Eisen, Jee Young Moon, Jamie B Rosenberg

Objective: Patients who are intubated and sedated are at risk for developing exposure keratopathy, which can lead to permanent vision loss. This retrospective study assesses the incidence of exposure keratopathy (EK) in intensive care unit (ICU) patients before and after implementation of an EK Prevention Order Set.

Methods: At one tertiary care hospital (Bronx, NY), an "Exposure Keratopathy Prevention Order Set" was implemented to ameliorate this risk which included the application of white petrolatum-mineral oil lubricating ointment every 6 hours in both eyes. This retrospective chart review study analyzed the incidence of EK diagnosis before and after implementation of this EK Prevention Order Set. Patients who were on mechanical ventilation at the time of ophthalmology consult request between January 1, 2021, and December 31, 2021, were included. Ophthalmology consult notes of patients with EK diagnosis were reviewed for details regarding the consult request, examination findings, diagnosis, and treatment plan.

Results: There were 247 and 361 ventilated ICU patients before and after the order set, respectively. The number of ophthalmology consults decreased slightly after the order set from 15 of 247 to 20 of 361 ventilated patients. In addition, the rate of EK among ventilated patients decreased from 4.5% (11 of 247 patients over 151 days) to 2.2% (8 of 361 patients over 212 days; P =0.154) with a risk ratio of 0.50 (95% CI 0.20-1.22).

Conclusion: The number of patients diagnosed with EK trended down after implementation of the EK Prevention Order Set.

目的:插管并服用镇静剂的患者有患暴露性角膜病变的风险,这可能导致永久性视力丧失。这项回顾性研究评估了重症监护室(ICU)患者在实施暴露性角膜病变预防令前后暴露性角膜病(EK)的发生率,实施了一套“暴露性角膜病变预防令”来减轻这种风险,其中包括每6小时在双眼涂抹一次白矿脂矿物油润滑膏。这项回顾性图表回顾研究分析了实施该EK预防令集前后EK诊断的发生率。2021年1月1日至2021年12月31日期间,在眼科咨询请求时接受机械通气的患者也包括在内。对诊断为EK的患者的眼科咨询记录进行了审查,以了解有关咨询请求、检查结果、诊断和治疗计划的详细信息。结果:在设定顺序之前和之后,分别有247名和361名ICU通气患者。排序后,眼科咨询的数量略有下降,从247名通气患者中的15名降至361名通气患者的20名。此外,通气患者的EK发生率从4.5%(247名患者中有11名在151天内)下降到2.2%(361名患者中的8名在212天内;P=0.154),风险比为0.50(95%CI 0.20-1.22)。结论:实施EK预防令后,诊断为EK的患者数量呈下降趋势。
{"title":"Assessing an Exposure Keratopathy Prevention Strategy in Mechanically Ventilated Patients: A Retrospective Study.","authors":"Ayobami Adebayo, Jenna Tauber, Jennifer Tingley, Lewis A Eisen, Jee Young Moon, Jamie B Rosenberg","doi":"10.1097/ICL.0000000000001055","DOIUrl":"10.1097/ICL.0000000000001055","url":null,"abstract":"<p><strong>Objective: </strong>Patients who are intubated and sedated are at risk for developing exposure keratopathy, which can lead to permanent vision loss. This retrospective study assesses the incidence of exposure keratopathy (EK) in intensive care unit (ICU) patients before and after implementation of an EK Prevention Order Set.</p><p><strong>Methods: </strong>At one tertiary care hospital (Bronx, NY), an \"Exposure Keratopathy Prevention Order Set\" was implemented to ameliorate this risk which included the application of white petrolatum-mineral oil lubricating ointment every 6 hours in both eyes. This retrospective chart review study analyzed the incidence of EK diagnosis before and after implementation of this EK Prevention Order Set. Patients who were on mechanical ventilation at the time of ophthalmology consult request between January 1, 2021, and December 31, 2021, were included. Ophthalmology consult notes of patients with EK diagnosis were reviewed for details regarding the consult request, examination findings, diagnosis, and treatment plan.</p><p><strong>Results: </strong>There were 247 and 361 ventilated ICU patients before and after the order set, respectively. The number of ophthalmology consults decreased slightly after the order set from 15 of 247 to 20 of 361 ventilated patients. In addition, the rate of EK among ventilated patients decreased from 4.5% (11 of 247 patients over 151 days) to 2.2% (8 of 361 patients over 212 days; P =0.154) with a risk ratio of 0.50 (95% CI 0.20-1.22).</p><p><strong>Conclusion: </strong>The number of patients diagnosed with EK trended down after implementation of the EK Prevention Order Set.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"70-72"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71488371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vision Correction Habits After COVID-19 Onset in Spectacle and Contact Lens Wearers. 眼镜和隐形眼镜佩戴者COVID-19发病后的视力矫正习惯
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-29 DOI: 10.1097/ICL.0000000000001061
Erin M Rueff, Elaine Y Chen, Andrew Loc Nguyen

Purpose: To determine how vision correction habits changed after the 2019 coronavirus disease (COVID-19) pandemic onset.

Methods: Participants reported vision correction habits, refractive error, screen time, mask wearing time, and dry eye symptoms since the COVID-19 pandemic onset through email survey.

Results: A total of 133 participants completed the survey. Worsening dry eye symptoms were associated with increased screen time ( P =0.04). Hours per day of spectacle wear increased by approximately 1 hr ( P =0.001) and was associated with increased screen time ( P =0.002). Worsening dry eye symptoms were associated with increased days per week of spectacle wear ( P =0.02). Participants wore contact lenses about one day per week less than before the pandemic ( P =0.0001). Increased mask wearing time was associated with increased days per week of contact lens wear ( P =0.03).

Conclusions: After pandemic onset, hours per day of spectacle wear increased, and days per week of contact lens wear decreased. Increases in hourly spectacle wear were associated with increased screen time, whereas increased daily contact lens wear was associated with increased mask wear time, suggesting that spectacles may be preferred for screen time activities and contact lenses for mask wear.

目的:了解2019冠状病毒病(COVID-19)大流行后视力矫正习惯的变化情况。方法:参与者通过电子邮件调查方式报告自COVID-19大流行以来的视力矫正习惯、屈光不正、屏幕使用时间、佩戴口罩时间和干眼症状。结果:共有133名参与者完成了调查。干眼症状加重与屏幕时间增加有关(P=0.04)。每天佩戴眼镜的时间增加了约1小时(P=0.001),并且与屏幕时间增加有关(P=0.002)。干眼症状加重与每周佩戴眼镜天数增加有关(P=0.02)。与疫情前相比,参与者每周佩戴隐形眼镜的时间减少了一天(P=0.0001)。佩戴口罩时间的增加与每周佩戴隐形眼镜天数的增加相关(P=0.03)。结论:大流行开始后,眼镜佩戴时间增加,每周隐形眼镜佩戴天数减少。每小时佩戴眼镜的次数增加与屏幕时间增加有关,而每天佩戴隐形眼镜的次数增加则与佩戴口罩的时间增加有关,这表明在屏幕时间活动中,眼镜可能更受欢迎,而佩戴隐形眼镜可能更受欢迎。
{"title":"Vision Correction Habits After COVID-19 Onset in Spectacle and Contact Lens Wearers.","authors":"Erin M Rueff, Elaine Y Chen, Andrew Loc Nguyen","doi":"10.1097/ICL.0000000000001061","DOIUrl":"10.1097/ICL.0000000000001061","url":null,"abstract":"<p><strong>Purpose: </strong>To determine how vision correction habits changed after the 2019 coronavirus disease (COVID-19) pandemic onset.</p><p><strong>Methods: </strong>Participants reported vision correction habits, refractive error, screen time, mask wearing time, and dry eye symptoms since the COVID-19 pandemic onset through email survey.</p><p><strong>Results: </strong>A total of 133 participants completed the survey. Worsening dry eye symptoms were associated with increased screen time ( P =0.04). Hours per day of spectacle wear increased by approximately 1 hr ( P =0.001) and was associated with increased screen time ( P =0.002). Worsening dry eye symptoms were associated with increased days per week of spectacle wear ( P =0.02). Participants wore contact lenses about one day per week less than before the pandemic ( P =0.0001). Increased mask wearing time was associated with increased days per week of contact lens wear ( P =0.03).</p><p><strong>Conclusions: </strong>After pandemic onset, hours per day of spectacle wear increased, and days per week of contact lens wear decreased. Increases in hourly spectacle wear were associated with increased screen time, whereas increased daily contact lens wear was associated with increased mask wear time, suggesting that spectacles may be preferred for screen time activities and contact lenses for mask wear.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"65-69"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138452923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Location of Corneal Pigmented Arc and Myopia Control Efficacy in Orthokeratology-Treated Children Using Pentacam Measurements. 使用 Pentacam 测量技术探索角膜色素弧的位置和角膜矫形治疗儿童的近视控制效果。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2024-01-09 DOI: 10.1097/ICL.0000000000001048
Yu-Kai Kuo, Lan-Hsin Chuang, Chi-Chun Lai, Pei-Chang Wu, Shin-Yi Chen, Hung-Chi Chen, Ling Yeung, Nan-Kai Wang, Yih-Shiou Hwang, Chun-Fu Liu

Objectives: To determine the location and intensity of the corneal pigmented arc in orthokeratology (ortho-k)-treated children and its relationship with annual axial length (AL) change using Pentacam.

Methods: This retrospective cohort study enrolled children aged 9 to 15 years who had been followed up for at least one year after ortho-k treatment for myopia control. A Pentacam was used to determine the location and intensity of pigmented arc after lens wear. Annual AL changes were further used as the outcome measurement to determine their relationships with the location and intensity of pigmented arc using generalized estimating equations (GEE).

Results: In total, 62 eyes from 33 patients (mean age 10.9 years) were included in our final analysis. The mean follow-up time was 30.6 months. The mean annual AL changes were 0.10 mm. Age statistically correlated with annual AL change (GEE, P= 0.033). In addition, the annual AL change was negatively associated with the relative vertical distance of the lowest density of pigmented arc point based on the visual center, pupil center, and corneal thinnest point after adjustment with age ( P =0.005, P =0.004, and P< 0.001, respectively).

Conclusions: Pentacam could be a useful tool for evaluating the location and intensity of the corneal pigmented arc. In addition, there was a negative correlation between the vertical distance of the pigmented arc and annual AL change. These findings may provide important information regarding myopia control, next-generation ortho-k design, and prescription.

目的使用 Pentacam 确定接受角膜矫形术(ortho-k)治疗的儿童角膜色素弧的位置和强度及其与年轴长(AL)变化的关系:这项回顾性队列研究招募了年龄在 9-15 岁之间的儿童,这些儿童在接受正视角膜治疗控制近视后接受了至少一年的随访。使用 Pentacam 确定戴镜后色素弧的位置和强度。使用广义估计方程(GEE)进一步将每年的AL变化作为结果测量,以确定其与色素弧的位置和强度之间的关系:共有 33 名患者的 62 只眼睛(平均年龄 10.9 岁)被纳入最终分析。平均随访时间为 30.6 个月。AL年平均变化为0.10毫米。年龄与 AL 的年变化呈统计学相关(GEE,P=0.033)。此外,根据视觉中心、瞳孔中心和角膜最薄点调整年龄后,AL 的年变化与色素弧最低密度点的相对垂直距离呈负相关(P=0.005、P=0.004 和 PConclusions):Pentacam 是评估角膜色素弧位置和强度的有用工具。此外,色素弧的垂直距离与 AL 的年变化呈负相关。这些发现可为近视控制、下一代矫形 K 光设计和处方提供重要信息。
{"title":"Exploring the Location of Corneal Pigmented Arc and Myopia Control Efficacy in Orthokeratology-Treated Children Using Pentacam Measurements.","authors":"Yu-Kai Kuo, Lan-Hsin Chuang, Chi-Chun Lai, Pei-Chang Wu, Shin-Yi Chen, Hung-Chi Chen, Ling Yeung, Nan-Kai Wang, Yih-Shiou Hwang, Chun-Fu Liu","doi":"10.1097/ICL.0000000000001048","DOIUrl":"10.1097/ICL.0000000000001048","url":null,"abstract":"<p><strong>Objectives: </strong>To determine the location and intensity of the corneal pigmented arc in orthokeratology (ortho-k)-treated children and its relationship with annual axial length (AL) change using Pentacam.</p><p><strong>Methods: </strong>This retrospective cohort study enrolled children aged 9 to 15 years who had been followed up for at least one year after ortho-k treatment for myopia control. A Pentacam was used to determine the location and intensity of pigmented arc after lens wear. Annual AL changes were further used as the outcome measurement to determine their relationships with the location and intensity of pigmented arc using generalized estimating equations (GEE).</p><p><strong>Results: </strong>In total, 62 eyes from 33 patients (mean age 10.9 years) were included in our final analysis. The mean follow-up time was 30.6 months. The mean annual AL changes were 0.10 mm. Age statistically correlated with annual AL change (GEE, P= 0.033). In addition, the annual AL change was negatively associated with the relative vertical distance of the lowest density of pigmented arc point based on the visual center, pupil center, and corneal thinnest point after adjustment with age ( P =0.005, P =0.004, and P< 0.001, respectively).</p><p><strong>Conclusions: </strong>Pentacam could be a useful tool for evaluating the location and intensity of the corneal pigmented arc. In addition, there was a negative correlation between the vertical distance of the pigmented arc and annual AL change. These findings may provide important information regarding myopia control, next-generation ortho-k design, and prescription.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"84-90"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eyes on the Lid: The Impact of Fibroblast Growth Factor Receptor Targeting Drug on Human Meibomian Gland. 眼睑上的眼睛:成纤维细胞生长因子受体靶向药物对人睑板腺的影响。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-21 DOI: 10.1097/ICL.0000000000001058
Xiaomin Chen, Yang Liu, Tian Zheng, Qiuyan Zhang, Yaoyao Ren, Yanru Shen, Min Ke

Objective: To determine whether fibroblast growth factor receptor (FGFR)-targeting drug could impact human meibomian gland.

Methods: We followed up with three patients who were using pemigatinib for 4 to 10 weeks. The patients were evaluated for their ocular surface disease index, best-corrected visual acuity, Schirmer test, cornea staining, meibum expressibility score, tear meniscus height, noninvasive tear film breakup time, and meibomian gland area. The distribution of the FGFR family, FGF7, and FGF10 were evaluated by immunofluorescence staining and Western blot in fresh tarsal tissues from deidentified patients who underwent lid plastic surgeries.

Results: All patients developed apparent meibomian gland atrophy, shortening and narrowing of ducts, and significantly increased meibum expressibility and decreased noninvasive tear film breakup time within 5 to 8 weeks. Laboratory evaluations confirmed that human meibomian gland expresses abundant fibroblast growth factor receptors.

Conclusions: These findings indicate that meibomian gland is a target tissue of FGFR inhibitors, and patients who use these drugs may develop meibomian gland dysfunction.

目的:探讨以成纤维细胞生长因子受体(FGFR)为靶点的药物对人睑板腺的影响。方法:对3例使用培伽替尼的患者进行4 ~ 10周的随访。评估患者的眼表疾病指数、最佳矫正视力、Schirmer试验、角膜染色、睑板表达性评分、撕裂半月板高度、无创撕裂膜破裂时间、睑板腺面积。通过免疫荧光染色和Western blot方法,对接受眼睑整形手术的未识别患者新鲜跗骨组织中FGFR家族、FGF7和FGF10的分布进行了评估。结果:所有患者在5 ~ 8周内均出现睑板腺明显萎缩,导管变短变窄,睑板表达能力明显提高,无创撕裂膜破裂时间明显缩短。实验室评估证实,人睑板腺表达丰富的成纤维细胞生长因子受体。结论:这些发现提示睑板腺是FGFR抑制剂的靶组织,使用这些药物的患者可能出现睑板腺功能障碍。
{"title":"Eyes on the Lid: The Impact of Fibroblast Growth Factor Receptor Targeting Drug on Human Meibomian Gland.","authors":"Xiaomin Chen, Yang Liu, Tian Zheng, Qiuyan Zhang, Yaoyao Ren, Yanru Shen, Min Ke","doi":"10.1097/ICL.0000000000001058","DOIUrl":"10.1097/ICL.0000000000001058","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether fibroblast growth factor receptor (FGFR)-targeting drug could impact human meibomian gland.</p><p><strong>Methods: </strong>We followed up with three patients who were using pemigatinib for 4 to 10 weeks. The patients were evaluated for their ocular surface disease index, best-corrected visual acuity, Schirmer test, cornea staining, meibum expressibility score, tear meniscus height, noninvasive tear film breakup time, and meibomian gland area. The distribution of the FGFR family, FGF7, and FGF10 were evaluated by immunofluorescence staining and Western blot in fresh tarsal tissues from deidentified patients who underwent lid plastic surgeries.</p><p><strong>Results: </strong>All patients developed apparent meibomian gland atrophy, shortening and narrowing of ducts, and significantly increased meibum expressibility and decreased noninvasive tear film breakup time within 5 to 8 weeks. Laboratory evaluations confirmed that human meibomian gland expresses abundant fibroblast growth factor receptors.</p><p><strong>Conclusions: </strong>These findings indicate that meibomian gland is a target tissue of FGFR inhibitors, and patients who use these drugs may develop meibomian gland dysfunction.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"102-105"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138177730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Contact Lens Care Solutions: PVP-I Disinfectant and HAD Wetting Agents From Japan. 隐形眼镜护理液的进展:日本PVP-I消毒液和HAD润湿剂。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2023-11-29 DOI: 10.1097/ICL.0000000000001060
Takashi Itokawa, Katsuhide Yamasaki, Takashi Suzuki, Shizuka Koh

Abstract: Half of the individuals who wear contact lenses use reusable lenses that require proper care. Improper contact lens (CL) care and using inadequate disinfecting solutions can lead to lens contamination, CL-related microbial keratitis, and Acanthamoeba keratitis. Oxidative disinfecting solutions, such as hydrogen peroxide, show higher efficacy than multipurpose solutions. Povidone-iodine (PVP-I), an oxidative disinfectant used in ophthalmic surgery, has been proven to be safe and effective. The PVP-I system, a CL disinfecting solution developed in Japan, has demonstrated excellent antimicrobial and antiviral properties. Although CL discomfort does not have a risk of ocular disorders with poor visual prognosis, such as keratitis, CL discomfort can still lead to lens dropout and thus needs to be addressed. To mitigate CL discomfort, it is essential to use disinfecting solutions containing surfactants and wetting agents that improve wettability of the lens surface. A CL solution containing hyaluronic acid derivatives (HADs) as wetting agents that permanently adhere to the lens surface to improve wettability of the lens surface was developed in Japan. There is potential for HAD to be integrated into various solutions. This article reviews the efficacy of novel PVP-I-based disinfecting solution and HAD wetting agents.

摘要:佩戴隐形眼镜的人中有一半使用可重复使用的镜片,需要适当的护理。不适当的隐形眼镜护理和使用不适当的消毒溶液可导致隐形眼镜污染、与隐形眼镜相关的微生物角膜炎和棘阿米巴角膜炎。氧化消毒液(如双氧水)比多用途消毒液效果更好。聚维酮碘(PVP-I)是一种用于眼科手术的氧化消毒剂,已被证明是安全有效的。PVP-I系统是日本开发的CL消毒溶液,具有优异的抗菌和抗病毒性能。虽然晶状体不舒服不会导致视力预后不良的眼部疾病,如角膜炎,但晶状体不舒服仍然会导致晶状体脱落,因此需要解决。为了减轻晶状体的不适,必须使用含有表面活性剂和润湿剂的消毒溶液,以提高晶状体表面的润湿性。日本开发了一种含透明质酸衍生物(HADs)的CL溶液,作为湿润剂,永久附着在镜片表面,以提高镜片表面的润湿性。有可能将HAD集成到各种解决方案中。本文综述了新型pvp - i型消毒液和HAD润湿剂的功效。
{"title":"Advances in Contact Lens Care Solutions: PVP-I Disinfectant and HAD Wetting Agents From Japan.","authors":"Takashi Itokawa, Katsuhide Yamasaki, Takashi Suzuki, Shizuka Koh","doi":"10.1097/ICL.0000000000001060","DOIUrl":"10.1097/ICL.0000000000001060","url":null,"abstract":"<p><strong>Abstract: </strong>Half of the individuals who wear contact lenses use reusable lenses that require proper care. Improper contact lens (CL) care and using inadequate disinfecting solutions can lead to lens contamination, CL-related microbial keratitis, and Acanthamoeba keratitis. Oxidative disinfecting solutions, such as hydrogen peroxide, show higher efficacy than multipurpose solutions. Povidone-iodine (PVP-I), an oxidative disinfectant used in ophthalmic surgery, has been proven to be safe and effective. The PVP-I system, a CL disinfecting solution developed in Japan, has demonstrated excellent antimicrobial and antiviral properties. Although CL discomfort does not have a risk of ocular disorders with poor visual prognosis, such as keratitis, CL discomfort can still lead to lens dropout and thus needs to be addressed. To mitigate CL discomfort, it is essential to use disinfecting solutions containing surfactants and wetting agents that improve wettability of the lens surface. A CL solution containing hyaluronic acid derivatives (HADs) as wetting agents that permanently adhere to the lens surface to improve wettability of the lens surface was developed in Japan. There is potential for HAD to be integrated into various solutions. This article reviews the efficacy of novel PVP-I-based disinfecting solution and HAD wetting agents.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"91-101"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138452921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Galápagosization: Diquafosol for Dry Eyes. 加拉帕戈斯化:治疗干眼症的 Diquafosol。
IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-02-01 Epub Date: 2024-01-09 DOI: 10.1097/ICL.0000000000001071
Shizuka Koh
{"title":"Galápagosization: Diquafosol for Dry Eyes.","authors":"Shizuka Koh","doi":"10.1097/ICL.0000000000001071","DOIUrl":"10.1097/ICL.0000000000001071","url":null,"abstract":"","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":"50 2","pages":"57-58"},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eye & Contact Lens-Science and Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1